APA (7th ed.) Citation

Newman, N. J., Gordon, S. E., Nock, C. J., Burant, C. J., & Wenzell, C. M. (2022). Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer. Journal of Hematology Oncology Pharmacy, 12(4), 180.

Chicago Style (17th ed.) Citation

Newman, Nicholas J., Sara E. Gordon, Charles J. Nock, Christopher J. Burant, and Candice M. Wenzell. "Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer." Journal of Hematology Oncology Pharmacy 12, no. 4 (2022): 180.

MLA (9th ed.) Citation

Newman, Nicholas J., et al. "Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer." Journal of Hematology Oncology Pharmacy, vol. 12, no. 4, 2022, p. 180.